Tag Archives: mla

Heart disease risk appears associated with breast cancer radiation

Several reports have suggested links between breast cancer radiation and long-term cardiovascular-related deaths, according to the study background. Researchers examined the radiation treatment plans of 48 patients with stage 0 through IIA breast cancer who were treated after 2005 at the New York University Department of Radiation Oncology. They calculated the association between radiation treatment factors, such as mean cardiac dose, cardiac risk, treatment side, body positioning and coronary events. …

New kit predicts most common lung cancer survival

It is a genomic-clinical method able to determinate the prognosis of a patient with lung adenocarcinoma by studying the expression levels of 30 genes and combining the results with other indicators such as age, gender or the stage of the tumor. From this study, patients are classified into phases and from this classification depends their prognosis and treatment…

Stealth nanoparticles lower drug-resistant tumors’ defenses

Paula T. Hammond and colleagues at the Koch Institute of Integrative Cancer Research at MIT note that triple-negative breast cancer (TNBC) is an aggressive disease that is difficult to treat with standard-of-care therapy, and patients’ prognoses are poor. These cancer cells evade treatment by ramping up the production of certain proteins that protect tumors from chemotherapy drugs…

New program makes prostate cancer treatment decisions easier

A recent clinical study published in the New England Journal of Medicine showed that mortality rates for early stage prostate cancer were the same for men who choose active surveillance such as periodic PSA testing and biopsy, versus those who chose to treat their disease immediately with radiation or surgery. The research suggested that in cases of low-risk prostate cancer, aggressive treatment may not offer a long term survival benefit, and yet is associated with a number of side effects such as urinary incontinence and sexual problems. However, the vast majority of men diagnosed with low-risk cancer undergo aggressive treatment rather than active surveillance…

High variability among primary care physicians in rate of PSA screening

Using complete Medicare Part A and B data for Texas, the researchers selected PCPs whose patient panels included at least 20 men 75 years or older without a prior diagnosis of prostate cancer. Primary care physicians were identified as generalist physicians who saw a man on 3 or more occasions in 2009. PSA screening rates for 2010 were estimated…

Adolescent’s weight, socioeconomic status may affect cancer later in life

Zohar Levi, MD, MHA, of the Rabin Medical Center in Israel, and his colleagues measured body mass index in one million Israeli adolescent males who underwent a general health examination at an average age of 17 years from 1967 to 2005, and through the country’s cancer registry, identified which of the participants later developed cancer. Participants were followed from 2.5 to almost 40 years, with an average follow-up of 18.8 years. The researchers were amazed to find that events — particularly weight and socioeconomic status — up to the age of 17 years had a tremendous impact upon cancer development later in life. …

Recommended treatment for bone metastases not widely used

“Palliative radiotherapy, comprising l or more fractions (i.e., treatments) of daily radiation, is the mainstay of treatment for painful bone metastases. In 2005, a U.S.-based randomized trial demonstrated no difference in pain relief between single- and multiple-fraction radiotherapy for uncomplicated bone metastases, confirming results from international trials,” according to background information in the article appearing in the October 9 issue of JAMA…

Battling defiant leukemia cells

Chronic myeloid leukemia (CML) is an aggressive cancer of the blood that is often treated with a drug called Imatinib (a.k.a. Gleevec). Although Gleevec is highly effective, some cancer cells can develop resistance to the drug. The mechanism that drives this resistance is not completely understood, but there is evidence that cancerous stem-like cells are particularly resistant and help to perpetuate disease. …

No viral cause for breast cancer and brain tumors

It has been scientifically proven that about 15 per cent of all cancer cases are the result of viral infection, but many researchers believe that even more cancers could be caused by viruses. Among other theories, it is suggested that the Epstein-Barr virus could be a possible cause of breast cancer and that the cytomegalovirus might cause the malignant brain tumour glioblastoma. Extremely comprehensive study "There is some controversy in that we have not found any viruses in these forms of cancer, but if there were any viral involvement in breast cancer and glioblastoma, it is likely that we would have found some trace of it…